Cosmos Health Statistics
Total Valuation
Cosmos Health has a market cap or net worth of $13.10 million. The enterprise value is $20.46 million.
Important Dates
The last earnings date was Thursday, November 14, 2024, after market close.
| Earnings Date | Nov 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Cosmos Health has 17.75 million shares outstanding. The number of shares has increased by 71.34% in one year.
| Current Share Class | 17.75M |
| Shares Outstanding | 17.75M |
| Shares Change (YoY) | +71.34% |
| Shares Change (QoQ) | +3.28% |
| Owned by Insiders (%) | 20.40% |
| Owned by Institutions (%) | 4.19% |
| Float | 12.47M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.22 |
| Forward PS | 0.71 |
| PB Ratio | 0.48 |
| P/TBV Ratio | 0.47 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.37 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.44, with a Debt / Equity ratio of 0.32.
| Current Ratio | 1.44 |
| Quick Ratio | 0.89 |
| Debt / Equity | 0.32 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -19.59 |
Financial Efficiency
Return on equity (ROE) is -51.27% and return on invested capital (ROIC) is -24.87%.
| Return on Equity (ROE) | -51.27% |
| Return on Assets (ROA) | -18.53% |
| Return on Capital (ROIC) | -24.87% |
| Revenue Per Employee | $455,627 |
| Profits Per Employee | -$174,416 |
| Employee Count | 123 |
| Asset Turnover | 0.82 |
| Inventory Turnover | 6.30 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -33.33% in the last 52 weeks. The beta is 3.14, so Cosmos Health's price volatility has been higher than the market average.
| Beta (5Y) | 3.14 |
| 52-Week Price Change | -33.33% |
| 50-Day Moving Average | 0.81 |
| 200-Day Moving Average | 0.85 |
| Relative Strength Index (RSI) | 47.75 |
| Average Volume (20 Days) | 409,376 |
Short Selling Information
The latest short interest is 363,495, so 2.05% of the outstanding shares have been sold short.
| Short Interest | 363,495 |
| Short Previous Month | 568,517 |
| Short % of Shares Out | 2.05% |
| Short % of Float | 2.92% |
| Short Ratio (days to cover) | 2.56 |
Income Statement
In the last 12 months, Cosmos Health had revenue of $56.04 million and -$21.45 million in losses. Loss per share was -$2.01.
| Revenue | 56.04M |
| Gross Profit | 4.54M |
| Operating Income | -20.16M |
| Pretax Income | -18.54M |
| Net Income | -21.45M |
| EBITDA | -19.04M |
| EBIT | -20.16M |
| Loss Per Share | -$2.01 |
Full Income StatementBalance Sheet
The company has $3.34 million in cash and $11.02 million in debt, giving a net cash position of -$7.69 million or -$0.43 per share.
| Cash & Cash Equivalents | 3.34M |
| Total Debt | 11.02M |
| Net Cash | -7.69M |
| Net Cash Per Share | -$0.43 |
| Equity (Book Value) | 34.98M |
| Book Value Per Share | 1.50 |
| Working Capital | 11.03M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$2.93 million and capital expenditures -$392,298, giving a free cash flow of -$3.32 million.
| Operating Cash Flow | -2.93M |
| Capital Expenditures | -392,298 |
| Free Cash Flow | -3.32M |
| FCF Per Share | -$0.19 |
Full Cash Flow StatementMargins
Gross margin is 8.10%, with operating and profit margins of -35.98% and -36.39%.
| Gross Margin | 8.10% |
| Operating Margin | -35.98% |
| Pretax Margin | -36.39% |
| Profit Margin | -36.39% |
| EBITDA Margin | -33.97% |
| EBIT Margin | -35.98% |
| FCF Margin | -34.87% |